Dyax Corp Profile

Dyax Corporation, a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema and other plasmakallikreinmediated disorders.. The public information regarding Dyax Corp's current market price is not available at this time.
NameDyax Corp
CEO and President and DirectorGustav ChristensenView All
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressBurlington, MA
ExchangeNASDAQ General Markets
IndustryBusiness Services
Phone617 225 2500
CurrencyUSD - US Dollar

Dyax Corp Directors

Dyax Corp Corporate Directors

Thomas Kempner Independent Director
Jennifer Robinson Associate Director, Investor Relations and Corporate Communications
James Fordyce Independent Director
Additionally see Investing Opportunities. Please also try Fund Screener module to find activelly-traded funds from around the world traded on over 30 global exchanges.
Search macroaxis.com